Moderato System in Patients With Hypertension

NAUnknownINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

February 1, 2021

Study Completion Date

March 30, 2023

Conditions
Hypertension, Resistant to Conventional TherapyAtrioventricular Block
Interventions
DEVICE

BackBeat Moderato System

Eligible patients randomized after optimization phase to PHC ON for 12 months. Patients continue standard or modified anti-hypertension medical regime at discretion of the investigator

DEVICE

BackBeat Moderato Sytsem

Eligible patients randomized after optimization phase to PHC OFF for 12 months. Patients continue standard or modified anti-hypertension medical regime at discretion of the investigator.

Trial Locations (4)

1090

UZ Brussel - Heart Rhythm Management Center, Brussels

08661

Vilnius University Hospital Santariskiu Klinikos, Vilnius

02-097

Samodzielnym Publicznym Centralnym Szpitalem Klinicznym, Warsaw

41-800

Silesian Center for Heart Diseases, Zabrze

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

MLM Medical Labs GmbH

INDUSTRY

collaborator

nabios GmbH

UNKNOWN

lead

BackBeat Medical Inc

INDUSTRY

NCT03757377 - Moderato System in Patients With Hypertension | Biotech Hunter | Biotech Hunter